Programme and Contents

Protein Cross-Linking, the European Science Foundation Transglutaminase Programme

Workshop on Transglutaminases, protein cross-linking, and coeliac disease
University of Tampere, Tampere, Finland, September 14-15, 2001

Workshop chair
Markku Mäki, University of Tampere, Finland and Laszlo Fesus, University of Debrecen, Hungary

Friday, September 14

8.30 Welcome. 

8.45-9.15 Markku Mäki, Institute of Medical Technology, University of Tampere, Tampere, Finland: Coeliac disease, gluten-induced disease entities, clinical aspects. 
9.15-9.30 Discussion 

9.30-10.00 Detlef Schuppan, Medizinische Klinik I mit Poliklinik der Friedrich-Alexander Universität Erlangen, Nürnberg, Germany: Tissue transglutaminase as coeliac disease autoantigen. 
10.00-10.15 Discussion 

10.15-10.45 Daniel Aeschlimann, Connective Tissue Biology Laboratories, School of Biosciences, Cardiff, UK: Transglutaminase: protein cross-linking enzymes 
in tissues and body fluids. 
10.45-11.00 Discussion 

11.00-11.30 Coffee break 

Transglutaminases 

11.30-11.50 Rolf Hilgenfeld, Institute of Molecular Biotechnology Jena, Jena, 
Germany
: Three-dimensional structures of transglutaminases. 
11.50-12.00 Discussion 

12.00-12.20 Carlo Bergamini, Department of Biochemistry and Molecular Biology, 
University of Ferrara, Ferrara, Italy
: Conformational states and functional properties of 
tissular transglutaminase. 
12.20-12.30 Discussion 

12.30-12.50 Mie-Jae Im, The Cleveland Clinic Foundation, Department of Molecular Cardiology, The Lerner Research Institute, Cleveland, USA: Cellular functions of TGII and its associated proteins, TGII involved cellular signalling. 
12.50-13.00 Discussion 

13.00-13.30 Morning free discussion 

13.30-14.30 Lunch 

14.30-14.50 Martin Griffin, The Nottingham Trent University, Faculty of Science and Mathematics, Department of Life Science, Nottingham, UK: Tissue transglutaminase and the extracellular matrix in relation to stabilisation and cell surface interactions in normal and pathological conditions. 
14.50-15.00 Discussion 

15.00-15.20 Peter Steinert, National Institutes of Health, Laboratory of Skin Biology, Bethesda, USA: Transglutaminases in skin development and disease. 
15.20-15.30 Discussion 

15.30-15.50 Gerry Melino, University of Rome "Tor Vergata", Department of Experimental Medicine and Biochemical Sciences, Rome, Italy: Analysis of the phenotype of the transglutaminase 2 knockout mice 
15.50-16.00 Discussion 

16.00-16.20 Miklós Sárdy, Institute for Biochemistry, University of Cologne, Köln, Germany: The role of the epidermal transglutaminase in coeliac disease and dermatitis herpetiformis. 
16.20-16.30 Discussion 

16.30-17.00 Coffee break 

Extracellular matrix and coeliac disease 

17.00-17.20 Patricia Simon-Assmann, INSERM, Development and Pathology of the digestive tract, Strasbourg, France: Intestinal mesenchymal-epithelial crosstalk: role of extracellular signals.
17.20-17.30 Discussion 

17.30-17.50 Thomas T MacDonald, Division of Infection, Allergy, Inflammation and Repair, University of Southampton School of Medicine, Southampton, UK: T cell control of extracellular matrix in the intestine. 
17.50-18.00 Discussion 

18.00-18.20 Marco Londei, The Kennedy Institute of Rheumatology, London, UK: Mechanism of induction of tissue transglutaminase in celiac disease. 
18.20-18.30 Discussion 

Gliadin, the trigger of coeliac disease

18.30-18.50 Herbert Wieser, Deutsche Forschungsanstalt für Lebensmittelchemie, 
Garching, Germany: Potential coeliac toxic amino acid sequences of cereal proteins 
18.50-19.00 Discussion 

19.00-19.30 Afternoon free discussion 

20.30- Dinner

Saturday, September 15

Tissue transglutaminase, T cells, antibodies and coeliac disease 

9.00-9.20 Frits Koning, Leiden University Medical Centre, Department of 
Immunohematology and Blood Transfusion, Leiden
, The Netherlands: The identification of toxic T cellstimulatory gluten peptides early in celiac disease. 
9.20-9.30 Discussion 

9.30-9.50 Ludvig M. Sollid, Institute of Immunology, University of Oslo, Oslo, Norway: Tissue transglutaminase and gluten T cell epitopes in coeliac disease. 
9.50-10.00 Discussion 

10.00-10.20 Esposito Carla, University of Salerno, Italy: Tissue transglutaminase in the 
normal and celiac small intestinal mucosa. 
10.20-10.30 Discussion 

10.30-11.00 Coffee break 


11.00-11.20 Hans Sjöström, Biochemistry Laboratory, The Panum Institute, Copenhagen, Denmark: Transglutaminase in the small intestine of normals and patients with coeliac disease.
 11.20-11.30 Discussion 

11.30-11.50 Ilma Korponay-Szabo, Heim Pál Children's Hospital, Department of Gastroenterology and Nephrology, Budapest, Hungary: Recognition of TG2 by coeliac autoantibodies - importance of TG2 conformations and cofactors. 
11.50-12.00 Discussion 

12.00-12.20 Roberto Marzari, University of Trieste, Department of Biology, Trieste, Italy: Antibodies to transglutaminase from phage display libraries. 
12.20-12.30 Discussion 

12.30-13.30 Lunch 

13.30-13.50 Riccardo Troncone, Universitá degli Studi di Napoli Federico II, Department of Pediatrics, Naples, Italy: Inhibition of tissue transglutaminase activity by specific antibodies from coeliac patients. 
13.50-14.00 Discussion 

14.00-14.20 Tuula Halttunen, Institute of Medical Technology, University of Tampere, Tampere, Finland: The role of disease specific IgA autoantibodies in coeliac disease pathogenesis. 
14.20-14.30 Discussion 

14.30-15.00 Free Discussion

Transglutaminase in cellular stress and apoptosis

15.00-15.20 Wilbert Boelens, University of Nijmegen, Department of Biochemistry, Nijmegen, The Netherlands: Involvement of transglutaminase in the formation of pathological inclusion bodies containing small heat shock proteins and cytoskeletal proteins.
15.20-15.30 Discussion 

15.30-15.50 Laszlo Fesus, University of Debrecen, Department of Biochemistry and  Molecular Biology, Medical and Health Sciences Center, Debrecen, Hungary: Ca-Transglutaminase; activation mechanism and action in cell death. 
15.50-16.00 Discussion. 

16.00-16.20 Mauro Piacentini, University of Rome "Tor Vergata", Department of Biology, Rome, Italy: Is "tissue" transglutaminase expression in celiac disease an apoptosis associated 
event? 
16.20-16.30 Discussion 

16.30-17.00 Coffee break 

17.00-18.30 Overall discussion, conclusions, future 

20.00- Dinner 

Free paper abstracts